LDH is commonly used in human cancer patients for prognostic purposes. Aim of this study was to determine the magnitude of serum LDH elevation in dogs with cancer compared to healthy dogs and dogs with non-neoplastic disease, and to verify whether it may support the diagnosis of specific malignancies. 128 healthy dogs, 211 diseased dogs and 188 cancer dogs were enrolled. Dogs with cancer had significantly higher LDH than diseased (P<0.001) and healthy dogs (P<0.001), but large overlap was found.
Introduction
Lactate dehydrogenase (LDH), which is expressed as 5 isoenzymes, is an ubiquitous glycolytic enzyme catalysing the final step in the glycolytic metabolism, by converting lactate to pyruvate thereby producing cellular energy. 1 In people, increased LDH activity has been found in patients with myocardial or pulmonary infarction, hepatic disorders, haemolysis, and myopathy. 2, 3 Additionally, LDH is one of the most common
In veterinary medicine, early detection of cancer is often challenging, partly due to the lack of adequate tumor markers. Thus, the diagnosis of cancer relies on tissue biopsy in the majority of cases.
By definition, tumor markers are biologic substances produced by neoplastic cells or by the host in response to the cancer; they are typically secreted into bloodstream, urine, stool and other body fluids, and can be detected by several methods. 13 Measuring tumor marker levels in addition to routine diagnostic tests may be useful to identify some types of cancer. 14, 15 Apart from diagnosis, tumor markers may also reflect the extent of cancer, predict the response to therapy, or facilitate the identification of recurrence during follow-up. 13 Little research about LDH and cancer has been carried out in veterinary medicine.
According to the literature, LDH increases in canine and feline lymphoma, 16, 17, 30, 31 the pathogenesis of which remains undetermined. For other specific tumors, including carcinomas and sarcomas, information are not yet available.
Altough occasionally a higher specificity of LDH in neoplasias is found if the isoenzymes are assessed separately, 5,7,16 total LDH measurement is sometimes preferred. 17, 33 While total LDH levels generally reflect presence of tissue damage, measurement of individual isoenzymes may give a clue on which organ or tissue is damaged.
Materials and methods

Selection of dogs
Healthy dogs presenting for periodical examination (including general health check and/or regular vaccination), untreated dogs with various non-neoplastic diseases, and untreated dogs with cancer, admitted to the Clinica Veterinaria L'Arca, were prospectively enrolled.
For each included case, signalment information was obtained. Dogs with non-neoplastic diseases were presented with a variety of clinical signs; they had no evidence of malignancy based on results of physical examination, blood work, thoracic radiography and/or abdominal ultrasound.
All cancer cases were diagnosed by means of cytology and flow cytometry (liquid tumors) or histopathology (solid tumors) and underwent complete staging work-up, including thoracic radiology, abdominal ultrasound, and evaluation of the regional lymph node. For hematopoietic cancer, histiocytic disease and mast cell tumors, cytological samples of the bone marrow were also obtained.
LDH evaluation
At presentation, blood from the jugular vein was sampled after 12-hours fasting, and the serum obtained by centrifugation was processed within 30 minutes. 
Statistical analysis
Results
Healthy dogs
One-hundred twenty-eight healthy dogs were enrolled. Median age was 7 years (range, 
Comparison among groups
Mean LDH concentration was significantly higher in tumor-bearing dogs than either healthy dogs or dogs with non-tumoral diseases. The latter group had significantly higher levels than healthy dogs ( fig. 1 ).
Considering specific tumors, mean LDH levels were significantly higher for dogs with lymphoma than either dogs with carcinoma or mast cell tumor (Figure 2 ). Differences were not observed with sarcoma, histiocytic sarcoma, and hyperadrenocorticism. 
Discussion
Early detection of cancer is still very challenging. Beside ultrasound, CT scan, magnetic resonance, and newer imaging techniques, such as positron emission tomography, are used for tumor staging and are considered helpful for early diagnosis. 18 Despite progresses, the minimum tumor size enabling detection with the afore-mentioned techniques is represented by 10 9 cells, a point at which successful intervention is often not possible. 19 Little data has been published in the veterinary literature on circulating diagnostic tumor markers, including acute phase proteins, [20] [21] [22] [23] [24] alpha-fetoprotein, [25] [26] [27] alkaline phosphatase, 28 ,29 thymidine kinase, 30, 31 and lipid-associated sialic acid, 32 yet their biologic significance has not been completely elucidated. High LDH levels were also reported in dogs and cats with lymphoma. 16, 17, 30, 31, 35 In this study, we assessed LDH levels in dogs with various types of cancer. Values recorded in dogs considered to be clinically healthy and in those affected by nonneoplastic diseases served as controls. Dogs with cancer were found to have significantly higher serum LDH levels than dogs in the healthy control group (P<0.001) and dogs with non-neoplastic diseases (P<0.001). Altogether, LDH was found to be increased in 43.6% of cancer cases. Among them, dogs with lymphoma had more often elevated LDH levels (78.2%) at presentation. Levels of LDH were higher in lymphoma than in either carcinoma (P<0.001) or mast cell tumors (P<0.05).
Although mean LDH levels were significantly higher in cancer patients (341.6 ± 342.5 U/l) than in dogs with non-neoplastic disease (232.8 ± 202.9 U/l) or in healthy individuals (142.3 ± 79.5 U/l), considerable overlap existed between groups, likely preventing its use as useful marker for tumor detection. In addition, about 50% of cases with proven malignancy had no LDH elevation at presentation, whereas 23.2% of dogs with non-neoplastic disease and 6.2% of healthy dogs had increased LDH, thereby indicating that a cut-off point discerning tumor-bearing negative and positive cases cannot be identified.
Also in the case of tumor types, LDH levels were largely overlapping. Thus, measuring activity of the enzyme has limited usefulness, especially in tumor-bearing dogs with normal LDH levels or when a tumor has been confirmed but its origin has not been clarified. Not unexpected, a correlation was found between age and LDH levels, likely due to the fact that older dogs are more likely to develop diseases. The negative correlation observed with PCV or albumin concentrations may suggest a shift towards anaerobic glycolysis in tissues, at least in part due to hypoxemia. 1 However, it must be noted that in each instance correlations were weak, questioning the value of the findings. 
